Solid Biosciences Inc. SLDB Return on equity

Return on equity at other companies

Sarepta Therapeutics, Inc.SRPT

-9.3%+2,662pp

BiogenBIIB

4.8%-4.3pp

Neurocrine BiosciencesNBIX

22.5%+10.1pp

InsmedINSM

-87.2%-27.3pp

RegenxbioRGNX

-137.6%-817pp

Dyne Therapeutics, Inc.DYN

-58.9%-4.4pp

FAQ

What is Solid Biosciences Inc.'s return on equity?

Solid Biosciences Inc. (SLDB) reported return on equity of -65.5% in Q2 2026.

How has Solid Biosciences Inc.'s return on equity changed year-over-year?

Solid Biosciences Inc.'s return on equity increased by 4.0% year-over-year, from -68.2% to -65.5%.

What is the long-term trend for Solid Biosciences Inc.'s return on equity?

Over 5 years (2020 to 2025), Solid Biosciences Inc.'s return on equity has grown at a 5.7% compound annual growth rate (CAGR), from -83.2% to -109.9%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.